Alex Dömling

Alex Dömling is Professor and External Collaborator at the University of Groningen's Faculty of Science and Engineering, affiliated with the Groningen Research Institute of Pharmacy. His research spans medicinal chemistry, organic synthesis, and drug discovery, with specialized expertise in multicomponent reactions and protein-protein interaction modulation.

Research interests focus on:

• Design and synthesis of bioactive compounds
• Development of novel synthetic methodologies
• Cancer immunotherapy targets (PD-1/PD-L1)
• Computational drug design approaches
• Protein-protein interaction inhibitors

Publication trends show consistent work in medicinal chemistry with recent expansion into metabolic health and immunotherapy. His highly cited work includes foundational research on multicomponent reactions and protein interaction antagonists.

Significant scientific recognition includes:

• Ranking among top 2% most influential researchers worldwide (2021)
• PITT Innovator Award (2011)
• ERUDITE Scholar in Residence (2011)
• Honorary Diploma (2012)